Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #10,411 to #10,460.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Ecothermy [282 bytes]
  2. (hist) Caudal cell mass [282 bytes]
  3. (hist) Dose concentration [282 bytes]
  4. (hist) Sanopreme [282 bytes]
  5. (hist) Sonogram [282 bytes]
  6. (hist) Pneumothorax medical therapy [282 bytes]
  7. (hist) Methicillin resistant staphylococcus aureus other imaging findings [282 bytes]
  8. (hist) Nutcracker esophagus electrocardiogram [282 bytes]
  9. (hist) Renal oncocytoma staging [282 bytes]
  10. (hist) Hydatiform mole historical perspective [282 bytes]
  11. (hist) Hydatiform mole classification [282 bytes]
  12. (hist) Hydatiform mole causes [282 bytes]
  13. (hist) Hydatiform mole differential diagnosis [282 bytes]
  14. (hist) Hydatiform mole epidemiology and demographics [282 bytes]
  15. (hist) Hydatiform mole screening [282 bytes]
  16. (hist) Hydatiform mole other imaging findings [282 bytes]
  17. (hist) Hydatiform mole other diagnostic studies [282 bytes]
  18. (hist) Hydatiform mole primary prevention [282 bytes]
  19. (hist) Hydatiform mole secondary prevention [282 bytes]
  20. (hist) Hydatiform mole cost-effectiveness of therapy [282 bytes]
  21. (hist) Hydatiform mole future or investigational therapies [282 bytes]
  22. (hist) Hydatiform mole case study one [282 bytes]
  23. (hist) Hyperprolactinemia case study one [282 bytes]
  24. (hist) Eosinophilia epidemiology and demographics [282 bytes]
  25. (hist) Methemoglobinemia chest x ray [282 bytes]
  26. (hist) Hemophagocytic lymphohistiocytosis other diagnostic studies [282 bytes]
  27. (hist) Solitary pulmonary nodule risk factors [282 bytes]
  28. (hist) Solitary pulmonary nodule historical perspective [282 bytes]
  29. (hist) Solitary pulmonary nodule natural history, complications and prognosis [282 bytes]
  30. (hist) Solitary pulmonary nodule primary prevention [282 bytes]
  31. (hist) Solitary pulmonary nodule cost-effectiveness of therapy [282 bytes]
  32. (hist) Solitary pulmonary nodule future or investigational therapies [282 bytes]
  33. (hist) Solitary pulmonary nodule case study one [282 bytes]
  34. (hist) Chronic bronchitis future or investigational therapies [282 bytes]
  35. (hist) Nephrocalcinosis pathophysiology [282 bytes]
  36. (hist) Schroeder syndrome 1 [282 bytes]
  37. (hist) Parotitis case study one [282 bytes]
  38. (hist) Parotitis CT [282 bytes]
  39. (hist) Parotitis other diagnostic studies [282 bytes]
  40. (hist) Clostridium difficile infection future or investigational therapies [282 bytes]
  41. (hist) Hypocalcemia future or investigational therapies [282 bytes]
  42. (hist) Nasal Congestion cost-effectiveness of therapy [282 bytes]
  43. (hist) Personality disorder cost-effectiveness of therapy [282 bytes]
  44. (hist) Fosfomycin contraindications [282 bytes]
  45. (hist) Colorado tick fever classification [282 bytes]
  46. (hist) Polyarteritis nodosa classification [282 bytes]
  47. (hist) Differentiating Diabetic neuropathy from other diseases [282 bytes]
  48. (hist) Differentiating Hyperaldosteronism from other diseases [282 bytes]
  49. (hist) Allergic colitis other diagnostic studies [282 bytes]
  50. (hist) Diaphragmatic hernia other diagnostic studies [282 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)